Salarius Pharmaceuticals Inc Working Capital to Net Assets Ratio
Salarius Pharmaceuticals Inc working capital to net assets ratio. Salarius Pharmaceuticals Inc (SLRX) has a Working Capital to Net Assets ratio of 116.8% as of September 2025. Working capital of $4.96 Million (current assets of $6.06 Million minus current liabilities of $1.10 Million) is measured against net assets of $4.25 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Salarius Pharmaceuticals Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Salarius Pharmaceuticals Inc (2014–2024)
Working capital to net assets ratio of Salarius Pharmaceuticals Inc from 2014 to 2024. This chart shows how Salarius Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 116.8%, reflecting working capital of $4.96 Million against net assets of $4.25 Million USD. See SLRX cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Salarius Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2014–2024)
Salarius Pharmaceuticals Inc working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Salarius Pharmaceuticals Inc from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SLRX current and non-current assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 97.7% | $1.48 Million | $1.51 Million | $2.99 Million | $1.51 Million | ▼ -1.1 pp |
| 2023 | 98.7% | $5.22 Million | $5.29 Million | $6.52 Million | $1.30 Million | ▼ 0.0 pp |
| 2022 | 98.7% | $10.25 Million | $10.38 Million | $14.52 Million | $4.27 Million | ▲ +26.3 pp |
| 2021 | 72.4% | $28.05 Million | $38.72 Million | $30.16 Million | $2.11 Million | ▲ +13.7 pp |
| 2020 | 58.8% | $13.02 Million | $22.16 Million | $15.80 Million | $2.77 Million | ▲ +45.7 pp |
| 2019 | 13.1% | $1.38 Million | $10.58 Million | $4.69 Million | $3.31 Million | ▼ -44.0 pp |
| 2018 | 57.1% | $5.30 Million | $9.28 Million | $10.32 Million | $5.02 Million | ▼ -41.5 pp |
| 2017 | 98.6% | $28.69 Million | $29.11 Million | $34.54 Million | $5.85 Million | ▼ -0.2 pp |
| 2016 | 98.8% | $58.58 Million | $59.32 Million | $62.47 Million | $3.89 Million | ▲ +1.8 pp |
| 2015 | 97.0% | $89.40 Million | $92.19 Million | $92.25 Million | $2.85 Million | ▲ +604.2 pp |
| 2014 | -507.2% | $33.16 Million | $-6.54 Million | $34.22 Million | $1.07 Million | — |